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Comparison of two procedures for routine IUD exchange in
women with positive Pap smears for actinomyces-like organisms
Abstract
BACKGROUND: In the female genital tract, up to 30% of Papanicolaou (Pap)-stained cervicovaginal
smears of intrauterine device (IUD) users are positive for actinomyces-like organisms (ALOs). Many
clinicians believe that no therapeutic intervention is necessary if women with ALOs are without
symptoms. However, there are no recommendations for the procedure in ALO-positive women with
need for a routine IUD exchange. STUDY DESIGN: In this retrospective study, the incidence of ALOs
was compared in ALO-positive women with a routine IUD exchange according to two new procedures:
Group 1 (n=19), insertion of a new IUD immediately after removal of the index device, and Group 2
(n=19) IUD removal and reinsertion after 3-5 days. A Pap smear was obtained at intervals of 6 weeks
and 12, 24 and 36 months after reinsertion. RESULTS: The cytological examination carried out after 6
weeks proved to be negative for ALOs in all cases. After 36 months, smears were more often positive
for ALOs in women with immediate IUD exchange (73% vs. 33%; p<.17). CONCLUSION: Our results
indicate that in ALO-positive women, IUD reinsertion immediately after removal or after an interval of
3-5 days is safe. The interval reinsertion might be of advantage on a long-term basis.
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 Abstract 
Background: In the female genital tract up to 30% of Papanicolaou-stained (PAP) 
cervicovaginal smears of  intrauterine device (IUD) users are positive for actinomyces-like 
organisms (ALOs). Many authors hold the view, that no therapeutic intervention is necessary, 
if women with ALOs are without symptoms. However, there are no recommendations for the 
procedure in ALOs positive women with need for a routine IUD exchange. 
Study design: In this retrospective study the incidence of Actinomyces-like organisms (ALOs) 
was compared in ALOs positive women with a routine IUD exchange according to two new 
procedures: Group 1 (n=19): insertion of a new IUD immediately after removal of the index 
device; group 2 (n=19) IUD removal and reinsertion after 3-5 days. A PAP smear was 
obtained at intervals of 6 weeks, 12 months, 24 and 36 months after reinsertion. 
Results: The cytological examination carried out after 6 weeks proved to be negative for 
ALOs in all cases. After 36 months smears were more often positive for ALOs in women with 
immediate IUD exchange (73% vs.33%; p<0.17). 
Conclusion: Our results indicate that in ALOs positive women IUD reinsertion immediately 
after removal or after an interval of 3-5 days are safe. The interval refit might be of advantage 
on a long-term basis. 
 
 2
 Introduction 
Actinomyces species are a gram-positive, non-acid fast anaerobic bacteria that exhibit 
branching filamentous growth (1). The organism does not cross mucosal barriers unless there 
is tissue injury (2). In the female genital tract up to 30% of Papanicolaou-stained (PAP) 
cervicovaginal smears of  intrauterine device (IUD) users are positive for actinomyces-like 
organisms (ALOs) (2-4). The rate is lower with the levonorgestrel-releasing device and 
increases with the duration of use (2, 5). Although actinomyces have been recognized as a 
commensal of the vagina in women, most authors found non-IUD wearers to be actinomyces-
free (6, 7). 
In symptomatic ALOs positive IUD users consistently  IUD removal and antibiotic treatment 
are recommended (2, 8, 9). The management of ALOs in the absence of significant symptoms 
however is difficult and controversial. Therapeutic recommendations  range from observation 
and controlling for the appearance of symptoms to the removal of the device with or without 
antibiotic treatment (2, 8, 10-13). 
No recommendations exist for the treatment of asymptomatic ALOs positive women, who 
need a routine exchange of their IUD after the approved lifespan. In our family planning 
clinic we used to remove the IUD during menstruation, performed a PAP smear 6 weeks later 
and inserted a new device if this smear was negative for ALOs. In accordance with many 
authors we found in all cases the PAP smear to be negative 6 weeks after IUD removal (14, 
15). However, although we spend a lot of time to instruct women for contraception during the 
two months interval without IUD several pregnancies occurred. Therefore we discussed the 
risks of the option to exchange the IUD immediately. Because pelvic actinomycotic abscess is 
rare we held the view that an immediate exchange or a shorter interval between removal and 
reinsertion should not put women on an increased risk, to develop pelvic actinomycosis, if 
disappearance of ALOs is checked by a PAP smear six weeks after reinsertion. From April 
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2000 on we offered to ALOs positive IUD carriers, who came for the exchange of their 
device, to directly reinsert an IUD or perform reinsertion after 3-5 days. In the present article 
we report the results of these two procedures, which we supposed to be more comfortable for 
the women and to be safe for the protection from pregnancies. 
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Material and methods 
A retrospective study was carried out to review all clinical cases of ALOs positive women 
with a routine exchange of an IUD according to two different new clinical procedures. 
Because we aimed to report a follow-up period of three years we included cases attending our 
Center for Family planning from 2000 up to 2003. From a list of all IUD insertions identified 
those women with a positive smear for ALOs within 6 weeks before exchange of the device. 
All women included used the Multiload 375 Copper-IUD (ML 375), which is recommended 
to be exchanged after five years. The protocol for this analysis has been submitted to the local 
ethical committee. The following investigations are part of our clinical routine performed 4-6 
weeks before IUD exchange: Pelvic examination, PAP smear, endocervical swab for 
Chlamydia trachomatis, vaginal smear for bacterial vaginosis or trichomoniasis and 
transvaginal ultrasound. Pathological PAP smears, positive swab for Chlamydia trachomatis 
or pelvic pain are reasons for IUD removal without reinsertion. The exchange is performed 
during the next menstruation, if PAP smear and Chlamydia swab are normal and if necessary 
after treatment of a vaginal infection. Women were included, when the smear 4-6 weeks prior 
to insertion was positive for ALOs. Depending on the women`s preferences the devices were 
either refitted immediately (group A) or after an interval of 3-5 days (group B). Sonographic 
control of the IUD position in the uterus was performed as part of our clinical routine 
immediately after insertion, 6 weeks later and later on annually. Information was given about 
the presence of  ALOs and about the necessity to obtain a PAP smear after six weeks to test 
for clearance of the organism. Furthermore women were informed about the incidence of 
pelvic actinomycosis and the possibility to remove colonisation with ALOs by removal of the 
device. All women were aware of the importance to report symptoms. Later on annual PAP 
smears were performed according to our local guidelines.  
Each smear was seen by one experienced pathologist. Over the observation period three 
different pathologists from the same cytological laboratory were involved in the analyses of 
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the PAP smears. Cytomorphologic characteristics for the cytological diagnosis of ALOs in the 
PAP-stained smears were the presence of basophilic conglomerates with a dense central part 
surrounded by intertwined filament-type formations.  
The main variable of this retrospective study is the appearance or non - appearance of ALOs 
in the cytological smear after IUD exchange. Disappearance of ALOs was considered to have 
occurred, when the cytological report of the post-intervention smear was negative. A further 
point of interest was the reappearance of ALOs with the two procedures over the observation 
period of 36 months.  
 
Statistical Analysis 
Fisher`s exact test was used to test the difference between incidence of ALOs in both groups. 
Student's t-test was used for comparison of baseline parameters. The level of significance was 
set at a p-value ≤ 0.05. Baseline data are given as mean (SD). All analyses were performed by 
using the Statview 4.01 data analyses software (Abacus Concepts, Berkeley, CA, USA).  
 
 
Results 
During the follow-up period 461 IUD insertions were performed. Before exchange of the IUD 
47 IUD carriers had ALOs positive smears and a device in situ for 5 years. Thirty-eight of 
these women wished an IUD reinsertion and obtained a follow-up smear 6 weeks after IUD 
exchange. Incidentally the number of women was identical in both intervention groups 
(n=19). The mean age of the participants did not differ between groups (direct exchange 37.9 
(7.49) years; interval exchange 37.5 (10.5) years). All women were carriers of a Multiload 
375 Copper-IUD (ML 375), whereas after exchange one person of each group obtained a 
Levonorgestrel-releasing device (LNG-IUD). The complete follow-up period of the cohort, 
was a total of 802 months. No actinomycotic abscess was observed. During the observation 
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period the number of women with follow-up decreased from 38 after 6 weeks to 20 after 36 
months (Table 1). The reasons for drop-out in each group are described subsequently. From 6 
weeks to 12 months three women were lost to follow-up, one woman wanted an IUD removal 
for personal reasons and 4 devices were removed because of partial or complete dislocation in 
group A. In group B there were 4 persons lost to follow-up during the same interval and three 
expulsions. Between 12 and 24 months there was one expulsion in group B. IUD dislocations 
and expulsions were diagnosed by routine vaginal sonogram. The number of participants in 
goup A was higher after 24 months in comparison with the number after 12 months, because 
one woman who did not attend the clinic after 12 months came for a smear after 24 and 36 
months. One expulsion and on IUD removal for personal reasons were the reason for two 
dropouts after 24 months in group B. 
In both groups all smears obtained 6 weeks after IUD exchange were negative for ALOs. 
Follow-up data for both groups are presented in Table 1. After 12-36 months there is a high 
rate of recolonisation with ALOs (table 1). Although more ALOs positive cases were 
observed after three years in the group with direct exchange this difference is not statistically 
significant. The 36 months smear of one woman with a LNG-IUD was ALOs negative. After 
exchange of the IUD all ALOs positive smears persisted to be positive during the whole 
follow-up period.  
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Discussion 
In the present study the incidence of ALOs reappearance after routine IUD exchange in ALOs 
positive women was investigated. The devices were inserted according to two clinical 
procedures. Both, IUD removal with immediate or interval refitting resulted in ALOs negative 
smears at the first cytological examination carried out after 6 weeks. At first sight this 
suggests, that immediate and interval IUD refitting is a good option for carriers of ALOs with 
need for a routine exchange. However, during longer follow-up we observed a trend to more 
ALOs positive smears in the group with direct IUD exchange, which increased with the 
duration of use (Table 1). Although the recolonisation rate is not significantly different after 
36 months, we suppose, that with longer follow-up the difference between groups might be 
relevant. The incidence of 73% ALOs positive smears three years after direct device exchange 
is very high in comparison with ML 375 users after interval exchange (33%), whereas the 
incidence after interval exchange is similar to that of users without a previous history of 
ALOs, which was reported to be 27% in our clinic after 36 months and 32.9% independent of  
duration of use.(5, 16) Other authors found a colonisation rate of 17% after 25-36 months of 
use, when inert and copper IUDs where included into the analysis(3). In carriers of the LNG-
IUD the incidence of ALOs positive smears is extremely low with 2.9%.5 Because in both 
groups only one person wished the insertion of an LNG-IUD, whereas all other women 
received a ML 375 device, variety in IUD-types between groups can not account for the 
distinct difference in ALOs recolonisation in the present study. However, before drawing 
clinical consequences of our results the following aspects have to be considered. Cytological 
diagnosis of actinomyces is difficult and the clinical significance of ALOs positive PAP 
smears is still uncertain (2, 7, 9, 17).  Several authors report a lack specificity of PAP smears 
in identifying actinomycetes (9, 18). False – positive identification can occur in the presence 
of Candida, Lepthotrix, Aspergillus and Eubactrium nodatum (4, 19). Therefore the term 
ALOs is preferable to actinomyces in reporting a PAP smear (2). ALOs positive smears 
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reflect colonisation but not necessarily infection. Under ordinary conditions Actinomyces do 
not cross mucosal barriers (2). However, if the mucosa is disrupted actinomycosis can result. 
On the other hand the diagnosis of severe pelvic actinomycosis is often delayed, because 
symptoms are modest in relation to the extensive disease (4, 20). Furthermore the low 
incidence of  actinomycotic abscesses in comparison with the high number and low precision 
of positive smears makes the management of ALOs positive IUD carriers difficult. In cases of 
IUD removal or exchange the high risk of pregnancy has to be balanced against the low risk 
for potential infection in future. Although today most authors agree to leave the IUD in situ if 
women do not develop symptoms, there are no recommendations for the procedure in cases of 
routine IUD exchange (7, 8, 10, 13, 16). One author reported seven cases of an immediate 
IUD exchange in ALOs positive women (15). All of these women were found to be ALOs 
negative six to twelve months later. The disappearance of ALOs after the removal of the 
device is in accordance with the idea that ALOs are normally confined to the IUD and the 
superficial layers of the endometrium and may be shed in the menstrual cycle once the foreign 
body is removed (15, 17). Although ALOs positive PAP smears are not very specific and 
pelvic actinomycosis is rare, our results indicate that interval refit is of advantage for routine 
IUD exchange in ALOs positive women. In contrast to other authors we never observed 
spontaneous disappearance of ALOs in the smear during follow-up (16).  
An important strength of our study is the long observation period, which allowed us to 
recognise that in spite of the fact that 100% of the smears obtained after 6 weeks were ALOs 
negative, ALOs may reappear more often, if there is no interval between removal and 
reinsertion. Our results are limited by the high dropout rate. The most common reason for 
dropout was IUD dislocation, which occurred  in seven cases during the first year after 
insertion. The dislocation rate was in the range reported previously for copper devices 
(21,22). The observation that most dislocations occurred during the first year is in accordance 
with data of other authors. (21,22).  
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In conclusion at the end of the lifespan immediate IUD exchange as well as removal and 
reinsertion after 3-5 days are sufficient to eliminate ALOs. The rate of ALOs reoccurrence 
may be higher with immediate exchange. Both procedures are more safe and convenient than 
a 6 week IUD-free interval. 
. 
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Table 1 
 
Actinomyces-like organisms (ALOs) in PAP smears of ALOs positive IUD users after exchange of  the device 
according to two different procedures 
 Immediate  exchange 
Group A 
Reinsertion after  3-5 days p – value 
Group B  
Interval since 
IUD exchange 
Number of 
women 
ALOs positive 
(%) 
Number of 
women 
ALOs positive 
(%) 
 
6 weeks 19 0 (0) 19 0 (0) > 0.99 
12 months 10 4 (40) 12 3 (25) 0.65 
24 months 11 7 (64) 11 4 (36) 0.39 
36 months 11 8 (73) 9 3 (33) 0.17 
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